首页> 外文OA文献 >Cost-effectiveness of roflumilast as an add-on treatment to long-acting bronchodilators in the treatment of COPD associated with chronic bronchitis in the United Kingdom

【2h】

Cost-effectiveness of roflumilast as an add-on treatment to long-acting bronchodilators in the treatment of COPD associated with chronic bronchitis in the United Kingdom

机译：罗氟司特作为长效支气管扩张剂在英国慢性支气管炎相关COpD治疗中的附加治疗的成本效益

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Yevgeniy Samyshkin; Robert W. Kotchie; Ann-Christin Mörk; Andrew H. Briggs; Eric D. Bateman;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Cost-effectiveness of roflumilast as an add-on treatment to long-acting bronchodilators in the treatment of COPD associated with chronic bronchitis in the United Kingdom [J] . Yevgeniy Samyshkin, Robert W. Kotchie, Ann-Christin Mork, The European journal of health economics: HEPAC : health economics in prevention and care . 2014,第1期

机译：在英国，罗氟司特作为长效支气管扩张剂的补充治疗在与慢性支气管炎相关的COPD中的成本效益
2. Cost-effectiveness of roflumilast as an add-on to triple inhaled therapy versus triple inhaled therapy in patients with severe and very severe COPD associated with chronic bronchitis in the UK [J] . Chris Kiff, Sandrine Ruiz, Nebibe Varol, International Journal of Chronic Obstructive Pulmonary Disease . 2018,第1期

机译：罗氟司特作为重度和非常重度COPD合并慢性支气管炎患者的三重吸入疗法与三重吸入疗法的附加药物
3. COST-EFFECTIVENESS OF ROFLUMILAST AS ADD-ON TO TRIPLE INHALED THERAPY VS TRIPLE INHALED THERAPY IN PATIENTS WITH SEVERE AND VERY SEVERE COPD ASSOCIATED WITH CHRONIC BRONCHITIS IN SWEDEN [J] . Engstrom A., Varol N. Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016,第7期

机译：瑞典慢性支气管炎伴重度和极重慢性阻塞性肺病的三联疗法与三联疗法相结合的罗氟司特的成本效益
4. Research Progress of TCM Treatment of Chronic Bronchitis in Remission Stage [C] . Hongjun Teng, Hongying Sun, Yu Shi International Conference on Electronics, Mechanics, Culture and Medicine . 2017

机译：缓解阶段中医治疗慢性支气管炎的研究进展
5. Treatment Patterns and Cost-Effectiveness of Chemotherapy Treatments among Advanced Gastric Cancer Patients [D] . Haag, Austin Jade. 2017

机译：晚期胃癌患者化学疗法的治疗模式和成本效益
6. Cost-effectiveness of roflumilast as an add-on treatment to long-acting bronchodilators in the treatment of COPD associated with chronic bronchitis in the United Kingdom [O] . Yevgeniy Samyshkin, Robert W. Kotchie, Ann-Christin Mörk, -1

机译：在英国罗氟司特作为长效支气管扩张剂的补充治疗在与慢性支气管炎相关的COPD中的成本效益
7. Cost-effectiveness of roflumilast as an add-on treatment to long-acting bronchodilators in the treatment of COPD associated with chronic bronchitis in the United Kingdom [O] . 2014

机译：在英国，罗氟司特作为长效支气管扩张剂的补充治疗在与慢性支气管炎相关的COPD中的成本效益

Cost-effectiveness of roflumilast as an add-on treatment to long-acting bronchodilators in the treatment of COPD associated with chronic bronchitis in the United Kingdom

著录项

引文网络

相似文献

相关主题

期刊订阅